Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | FFAR2 | O15552 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | CPT1A | P50416 | 4/20 | 0.32 |
| ▸ | CPT2 | P23786 | 3/20 | 0.32 |
| ▸ | KDM1A | O60341 | 2/20 | 0.32 |
| ▸ | CPT1B | Q92523 | 3/20 | 0.32 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | PRKACA | P17612 | 1/20 | 0.30 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38331 | 1.00 | CNR2 (0.41) | CNR2FFAR2SMN1; SMN2CPT1ACPT2 | |
| SCHEMBL38722 | 0.99 | CNR2 (0.41) | CNR2FFAR2SMN1; SMN2CPT1ACPT2 | |
| SCHEMBL38723 | 0.99 | CNR2 (0.41) | CNR2FFAR2SMN1; SMN2CPT1ACPT2 | |
| SCHEMBL38795 | 0.98 | CNR2 (0.41) | CNR2FFAR2SMN1; SMN2CPT1ACPT2 | |
| SCHEMBL38794 | 0.98 | CNR2 (0.41) | CNR2FFAR2SMN1; SMN2CPT1ACPT2 | |
| SCHEMBL38608 | 0.90 | FFAR2 (0.37) | CNR2FFAR2SMN1; SMN2CPT1ACPT2 | |
| SCHEMBL38515 | 0.90 | FFAR2 (0.37) | CNR2FFAR2SMN1; SMN2CPT1ACPT2 | |
| SCHEMBL38514 | 0.90 | FFAR2 (0.37) | CNR2FFAR2SMN1; SMN2CPT1ACPT2 | |
| SCHEMBL38606 | 0.90 | FFAR2 (0.37) | CNR2FFAR2SMN1; SMN2CPT1ACPT2 | |
| SCHEMBL38607 | 0.90 | FFAR2 (0.37) | CNR2FFAR2SMN1; SMN2CPT1ACPT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011151436-A2 | NOVEL COMPOUNDS, METHOD FOR USE THEM AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | EUROSCREEN S.A. (BE) | 2011-12-08 | — | — | WO | claimed |